Cryptococcosis

Common Name(s)

Cryptococcosis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Cryptococcosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Cryptococcosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Cryptococcosis" returned 246 free, full-text research articles on human participants. First 3 results:

Images in clinical medicine. Disseminated cryptococcosis.
 

Author(s): Guillaume Martin-Blondel, Loic Ysebaert

Journal: N. Engl. J. Med.. 2014 May;370(18):1741.

 

Last Updated: 5 May 2014

Go To URL
Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis.
 

Author(s): Wilber Sabiiti, Emma Robertson, Mathew A Beale, Simon A Johnston, Annemarie E Brouwer, Angela Loyse, Joseph N Jarvis, Andrew S Gilbert, Matthew C Fisher, Thomas S Harrison, Robin C May, Tihana Bicanic

Journal: J. Clin. Invest.. 2014 May;124(5):2000-8.

 

Cryptococcal meningitis (CM) is a leading cause of HIV-associated mortality globally. High fungal burden in cerebrospinal fluid (CSF) at diagnosis and poor fungal clearance during treatment are recognized adverse prognostic markers; however, the underlying pathogenic factors that ...

Last Updated: 5 May 2014

Go To URL
Changes of Th1/Th2 cytokines in immunocompetent patients with pulmonary cryptococcosis.
 

Author(s): J L Wang, S Y Li, Y F Luo, Y P Zhai, X Q Wei

Journal:

 

The aim of this study was to investigate the changes of Th1/Th2 cytokines in immunocompetent patients with pulmonary cryptococcosis (PC). Twenty immunocompetent patients with PC were identified by histopathological examination and were enrolled in the study along with the age- and ...

Last Updated: 4 Dec 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Cryptococcosis" returned 18 free, full-text review articles on human participants. First 3 results:

Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.
 

Author(s): Angela Loyse, Françoise Dromer, Jeremy Day, Olivier Lortholary, Thomas S Harrison

Journal: J. Antimicrob. Chemother.. 2013 Nov;68(11):2435-44.

 

Current, widely accepted guidelines for the management of HIV-associated cryptococcal meningoencephalitis (CM) recommend amphotericin B combined with flucytosine (5-FC) for ≥2 weeks as the initial induction treatment of choice. However, access to flucytosine in Africa and Asia, ...

Last Updated: 17 Oct 2013

Go To URL
Opportunistic yeast infections: candidiasis, cryptococcosis, trichosporonosis and geotrichosis.
 

Author(s): Denisse Vázquez-González, Ana María Perusquía-Ortiz, Max Hundeiker, Alexandro Bonifaz

Journal: J Dtsch Dermatol Ges. 2013 May;11(5):381-93; quiz 394.

 

Opportunistic yeast infections are diseases caused by fungi which normally are saprophytic and do not cause disease in humans or animals. The prevalence of these diseases has been increasing due to immunosuppressive, corticosteroid, and long-term antibiotic treatment following organ ...

Last Updated: 29 Apr 2013

Go To URL
Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases.
 

Author(s): C Bernard, D Maucort-Boulch, L Varron, C Charlier, K Sitbon, N Freymond, D Bouhour, A Hot, A C Masquelet, D Valeyre, N Costedoat-Chalumeau, M Etienne, I Gueit, S Jouneau, P Delaval, L Mouthon, J Pouget, J Serratrice, J-P Brion, F Vaylet, C Bremont, J M Chennebault, S Jaffuel, C Broussolle, O Lortholary, P Sève,

Journal: QJM. 2013 Jun;106(6):523-39.

 

To describe the main characteristics and the treatment of cryptococcosis in patients with sarcoidosis.

Last Updated: 30 May 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Evaluation and Follow-up of Patients With Cryptococcosis
 

Status: Recruiting

Condition Summary: Cryptococcosis; Lymphopenia

 

Last Updated: 14 Mar 2014

Go to URL
Operational Research for Cryptococcal Antigen Screening
 

Status: Recruiting

Condition Summary: Cryptococcal Meningitis; Cryptococcus Neoformans; Cryptococcosis

 

Last Updated: 30 Jun 2014

Go to URL
Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis
 

Status: Recruiting

Condition Summary: Cryptococcosis or Aspergillosis Infections

 

Last Updated: 6 Jun 2011

Go to URL